HAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHHAHAHAHHA
HAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAH
AHAHAHAHAHAHAHAHAHHAHAHAHHAHAHAHAHAHAHAHAHAHAHAHAHAHA
AHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAH
AHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAH
HAHAHAHAHAHAHAHAHAHAHAHAHHAHAHAHHAHAHAHAHAHAHAHAHAHAHA
AHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHA… HA.
Man, isn’t karma a ~gorge~ concept when it comes to fruition?
Man, isn’t karma a ~gorge~ concept when it comes to fruition?
You may remember Martin Shkreli, the steaming douchepot CEO of Turing Pharmaceuticals? He’s the one who decided that hiking up a one-of-a-kind medication from $13.50 to a whopping $750 per dose was a great idea.
He obviously faced a shit-tonne of backlash, due to the fact that sufferers couldn’t afford their necessary medication, and it was the only one on the market. Just ruining people’s lives for bucketloads of cash, nbd, right? Truly, wholly and absolutely evil.
But now, it appears there’s good in the world.
A San Diego company, Imprimis Pharmaceuticals Inc., has decided to begin selling a generic version of Turing’s Daraprim medication. But rather than hike the price up to $750 like Shkreli did, they are selling doses for only a dollar. They’ll be selling a bottle of 100 tablets, for $99.
Meanwhile, Shkreli said last month that he would lower Daraprim prices, but he hasn’t yet. HOPE YA GO BROKE, FUCKO! 
via CTV.
